Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sidney M Wolfe

Showing results (11-20 of 42) with videos related to

Pageof 5
Sort By:
The New England Journal of Medicine|February 15, 2002
Direct-to-consumer advertising--education or emotion promotion?Sidney M Wolfe
JAMA Internal Medicine|August 16, 2014
Proposed US Food and Drug Administration guidance for industry on distributing medical publications about the risks of prescription drugs and biological products: a misguided approachSidney M Wolfe
Medgenmed : Medscape General Medicine|April 15, 2006
There have been inadequate warnings that erectile dysfunction drugs can cause blindnessSidney M Wolfe
Health Matrix (Cleveland, Ohio : 1991)|September 5, 2006
Schroeder Lecture. Worst pills, best pillsSidney M Wolfe
BMJ (Clinical Research Ed.)|July 11, 2013
US study criticized for experimentation with premature infantsSidney M Wolfe
Academic Medicine : Journal of the Association of American Medical Colleges|January 15, 2002
The destruction of medicine by market forces: teaching acquiescence or resistance and change?Sidney M Wolfe
Lancet (London, England)|June 29, 2004
Dangers of rosuvastatin identified before and after FDA approvalSidney M Wolfe
BMJ (Clinical Research Ed.)|October 19, 2013
Selling amphetamine emblazoned athletic shirts v overselling amphetamines: a tale of two entrepreneursSidney M Wolfe
BMJ (Clinical Research Ed.)|August 7, 2014
Does $760 m a year of industry funding affect the FDA's drug approval process?Sidney M Wolfe
JAMA Internal Medicine|September 12, 2022
Curbing the Financial Incentives That Contribute to the High Prices of Prescription Drugs in the USSidney M Wolfe
Pageof 5

Showing results (11-20 of 42) with videos related to

Sort By:
Pageof 5
The New England Journal of Medicine|February 15, 2002
Direct-to-consumer advertising--education or emotion promotion?Sidney M Wolfe
JAMA Internal Medicine|August 16, 2014
Proposed US Food and Drug Administration guidance for industry on distributing medical publications about the risks of prescription drugs and biological products: a misguided approachSidney M Wolfe
Medgenmed : Medscape General Medicine|April 15, 2006
There have been inadequate warnings that erectile dysfunction drugs can cause blindnessSidney M Wolfe
Health Matrix (Cleveland, Ohio : 1991)|September 5, 2006
Schroeder Lecture. Worst pills, best pillsSidney M Wolfe
BMJ (Clinical Research Ed.)|July 11, 2013
US study criticized for experimentation with premature infantsSidney M Wolfe
Academic Medicine : Journal of the Association of American Medical Colleges|January 15, 2002
The destruction of medicine by market forces: teaching acquiescence or resistance and change?Sidney M Wolfe
Lancet (London, England)|June 29, 2004
Dangers of rosuvastatin identified before and after FDA approvalSidney M Wolfe
BMJ (Clinical Research Ed.)|October 19, 2013
Selling amphetamine emblazoned athletic shirts v overselling amphetamines: a tale of two entrepreneursSidney M Wolfe
BMJ (Clinical Research Ed.)|August 7, 2014
Does $760 m a year of industry funding affect the FDA's drug approval process?Sidney M Wolfe
JAMA Internal Medicine|September 12, 2022
Curbing the Financial Incentives That Contribute to the High Prices of Prescription Drugs in the USSidney M Wolfe
Pageof 5